Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced today that management will participate…
— Chris Lowe Promoted to Chief Operating Officer and Chief Financial Officer — Ted Monohon Promoted to Chief Accounting Officer…
– Total Revenues of $270.1 Million for the Fourth Quarter of 2020, $987.5 Million for the Full Year 2020 –…
– Submission Based on Positive Pivotal innovaTV 204 Trial Results Presented at the European Society of Medical Oncology Virtual Congress…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated…
PARIS–(BUSINESS WIRE)–WhiteLab Genomics, a specialist in artificial intelligence applied to gene and cell therapies, has signed a partnership agreement with…
Armed with the unique Optimum™ solution, Texas Medical Technology will deliver its advanced array of products with an effective, sustainable,…
SEATTLE–(BUSINESS WIRE)–#AdvancedGlycation–According to Coherent Market Insights, the global advanced glycation end products market is estimated to be valued at US$…
SEATTLE–(BUSINESS WIRE)–#cancer—Seattle Cancer Care Alliance (SCCA) today marked the 20th anniversary of opening the doors of its first clinic in…